Evaluate the Immunogenicity of a Novel Glucagon Formulation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01959334
Recruitment Status : Completed
First Posted : October 10, 2013
Last Update Posted : May 25, 2016
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2014
  Actual Study Completion Date : January 2015
  Certification/Extension First Submitted : July 7, 2015